The commitment to inclusivity in clinical trials, as seen with AC Immune’s focus on the Down syndrome community, is also a positive step towards comprehensive care for all affected individuals.
As the scientific community continues to unravel the complexities of Alzheimer’s, the future holds the promise of more targeted and effective treatments. The commitment to inclusivity in clinical trials, as seen with AC Immune’s focus on the Down syndrome community, is also a positive step towards comprehensive care for all affected individuals.